# A Microdose Evaluation Study of ABY-029 in Recurrent Glioma

> **NCT02901925** · EARLY_PHASE1 · COMPLETED · sponsor: **Dartmouth-Hitchcock Medical Center** · enrollment: 14 (actual)

## Conditions studied

- Glioma

## Interventions

- **DRUG:** ABY-029

## Key facts

- **NCT ID:** NCT02901925
- **Lead sponsor:** Dartmouth-Hitchcock Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-13
- **Primary completion:** 2021-06-29
- **Final completion:** 2021-06-29
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2024-12-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02901925

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02901925, "A Microdose Evaluation Study of ABY-029 in Recurrent Glioma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02901925. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*